Figure 3From: Role of E2F1-Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAsTime course effects of the selected siRNAs on CSMC proliferation. (A) Inhibition of CSMC proliferation, as evaluated by BrdU incorporation, lasted up to d 5 post transfection; the kinetics of cell proliferation reduction for siRNA-treated cells was mathematically evaluated by equation 1 (black lines); cumulative data from both donors are expressed as mean ± SEM, n = 6. (B–D) Proliferation inhibition was paralleled by a concomitant reduction of target proteins; shown are representative blots from donor 1 performed using Cellfectin as transfectant; #all the numbers reported below the blots derive from band quantification normalized to GAPDH and are expressed as the ratio of siGL2 treatment; *P < 0.02 compared with controls, n = 4; NTC, nontreated cells; siGL2, control siRNA-treated cells.Back to article page